BEAM
Price
$17.16
Change
-$0.45 (-2.55%)
Updated
Aug 11 closing price
Capitalization
1.74B
90 days until earnings call
LXEO
Price
$4.44
Change
-$0.09 (-1.99%)
Updated
Aug 11 closing price
Capitalization
239.68M
6 days until earnings call
Interact to see
Advertisement

BEAM vs LXEO

Header iconBEAM vs LXEO Comparison
Open Charts BEAM vs LXEOBanner chart's image
Beam Therapeutics
Price$17.16
Change-$0.45 (-2.55%)
Volume$1.94M
Capitalization1.74B
Lexeo Therapeutics
Price$4.44
Change-$0.09 (-1.99%)
Volume$212.39K
Capitalization239.68M
BEAM vs LXEO Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. LXEO commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and LXEO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (BEAM: $17.17 vs. LXEO: $4.44)
Brand notoriety: BEAM and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 87% vs. LXEO: 44%
Market capitalization -- BEAM: $1.74B vs. LXEO: $239.68M
BEAM [@Biotechnology] is valued at $1.74B. LXEO’s [@Biotechnology] market capitalization is $239.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and LXEO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while LXEO’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • LXEO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -10.22% price change this week, while LXEO (@Biotechnology) price change was -6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.16%. For the same industry, the average monthly price growth was +18.55%, and the average quarterly price growth was +17.82%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

LXEO is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+8.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.74B) has a higher market cap than LXEO($240M). BEAM YTD gains are higher at: -30.786 vs. LXEO (-32.523). LXEO has higher annual earnings (EBITDA): -107.14M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. LXEO (99.8M). LXEO has less debt than BEAM: LXEO (9.4M) vs BEAM (158M). BEAM has higher revenues than LXEO: BEAM (63.6M) vs LXEO (0).
BEAMLXEOBEAM / LXEO
Capitalization1.74B240M723%
EBITDA-399.03M-107.14M372%
Gain YTD-30.786-32.52395%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B99.8M1,222%
Total Debt158M9.4M1,681%
TECHNICAL ANALYSIS
Technical Analysis
BEAMLXEO
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 21 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRMTX170.23N/A
N/A
T. Rowe Price Comm & Tech Investor
HGHYX39.05N/A
N/A
Hartford Healthcare Y
SUVQX12.94N/A
N/A
PGIM Quant Solutions Large-Cap Val R6
APHRX35.13-0.16
-0.45%
Artisan Global Opportunities Instl
JEGRX17.59-0.09
-0.51%
Janus Henderson Global Sust Eq R

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-1.99%
ARWR - LXEO
49%
Loosely correlated
+4.81%
BEAM - LXEO
45%
Loosely correlated
-2.58%
COGT - LXEO
44%
Loosely correlated
-0.27%
RGNX - LXEO
43%
Loosely correlated
-4.97%
CGON - LXEO
41%
Loosely correlated
-3.62%
More